Cargando…
HDAC and HDAC Inhibitor: From Cancer to Cardiovascular Diseases
Histone deacetylases (HDACs) are epigenetic regulators that regulate the histone tail, chromatin conformation, protein-DNA interaction, and even transcription. HDACs are also post-transcriptional modifiers that regulate the protein acetylation implicated in several pathophysiologic states. HDAC inhi...
Autores principales: | Yoon, Somy, Eom, Gwang Hyeon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chonnam National University Medical School
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4742605/ https://www.ncbi.nlm.nih.gov/pubmed/26865995 http://dx.doi.org/10.4068/cmj.2016.52.1.1 |
Ejemplares similares
-
HDAC Inhibitors: Therapeutic Potential in Fibrosis-Associated Human Diseases
por: Yoon, Somy, et al.
Publicado: (2019) -
Involvement of HDAC1 and HDAC3 in the Pathology of Polyglutamine Disorders: Therapeutic Implications for Selective HDAC1/HDAC3 Inhibitors
por: Thomas, Elizabeth A.
Publicado: (2014) -
Metabolism, HDACs, and HDAC Inhibitors: A Systems Biology Perspective
por: King, Jacob, et al.
Publicado: (2021) -
Nitrosative Stress and Human Disease: Therapeutic Potential of Denitrosylation
por: Yoon, Somy, et al.
Publicado: (2021) -
Chimeric Antigen Receptor T Cell Therapy: A Novel Modality for Immune Modulation
por: Yoon, Somy, et al.
Publicado: (2020)